nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—COMT—telencephalic ventricle—Alzheimer's disease	0.0303	0.249	CbGeAlD
Dobutamine—Ventricular extrasystoles—Donepezil—Alzheimer's disease	0.0173	0.0592	CcSEcCtD
Dobutamine—Masoprocol—IGF1R—Alzheimer's disease	0.0157	0.539	CrCbGaD
Dobutamine—Skin exfoliation—Memantine—Alzheimer's disease	0.0135	0.0464	CcSEcCtD
Dobutamine—Hypokalaemia—Galantamine—Alzheimer's disease	0.0133	0.0456	CcSEcCtD
Dobutamine—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.0132	0.0454	CcSEcCtD
Dobutamine—Phlebitis—Memantine—Alzheimer's disease	0.0119	0.0409	CcSEcCtD
Dobutamine—Phlebitis—Rivastigmine—Alzheimer's disease	0.0117	0.04	CcSEcCtD
Dobutamine—Hypokalaemia—Donepezil—Alzheimer's disease	0.0103	0.0353	CcSEcCtD
Dobutamine—Angina pectoris—Donepezil—Alzheimer's disease	0.00954	0.0327	CcSEcCtD
Dobutamine—Hypokalaemia—Memantine—Alzheimer's disease	0.00937	0.0321	CcSEcCtD
Dobutamine—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00916	0.0314	CcSEcCtD
Dobutamine—Angina pectoris—Memantine—Alzheimer's disease	0.00866	0.0297	CcSEcCtD
Dobutamine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00848	0.029	CcSEcCtD
Dobutamine—COMT—forebrain—Alzheimer's disease	0.00792	0.0651	CbGeAlD
Dobutamine—Palpitations—Galantamine—Alzheimer's disease	0.00778	0.0267	CcSEcCtD
Dobutamine—Chest pain—Galantamine—Alzheimer's disease	0.0075	0.0257	CcSEcCtD
Dobutamine—COMT—telencephalon—Alzheimer's disease	0.00729	0.0599	CbGeAlD
Dobutamine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00704	0.0241	CcSEcCtD
Dobutamine—Tachycardia—Galantamine—Alzheimer's disease	0.00702	0.024	CcSEcCtD
Dobutamine—Hypotension—Galantamine—Alzheimer's disease	0.00672	0.023	CcSEcCtD
Dobutamine—ADRB1—forebrain—Alzheimer's disease	0.00671	0.0552	CbGeAlD
Dobutamine—ADRB1—telencephalon—Alzheimer's disease	0.00617	0.0507	CbGeAlD
Dobutamine—Chest pain—Donepezil—Alzheimer's disease	0.00581	0.0199	CcSEcCtD
Dobutamine—CA2—embryo—Alzheimer's disease	0.00557	0.0457	CbGeAlD
Dobutamine—Palpitations—Memantine—Alzheimer's disease	0.00548	0.0188	CcSEcCtD
Dobutamine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00545	0.0187	CcSEcCtD
Dobutamine—Palpitations—Rivastigmine—Alzheimer's disease	0.00536	0.0184	CcSEcCtD
Dobutamine—Chest pain—Memantine—Alzheimer's disease	0.00528	0.0181	CcSEcCtD
Dobutamine—Hypotension—Donepezil—Alzheimer's disease	0.00521	0.0178	CcSEcCtD
Dobutamine—Chest pain—Rivastigmine—Alzheimer's disease	0.00516	0.0177	CcSEcCtD
Dobutamine—Dyspnoea—Donepezil—Alzheimer's disease	0.00497	0.017	CcSEcCtD
Dobutamine—Thrombocytopenia—Memantine—Alzheimer's disease	0.00495	0.017	CcSEcCtD
Dobutamine—Tachycardia—Memantine—Alzheimer's disease	0.00494	0.0169	CcSEcCtD
Dobutamine—CA2—forebrain—Alzheimer's disease	0.00492	0.0405	CbGeAlD
Dobutamine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00485	0.0166	CcSEcCtD
Dobutamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00483	0.0165	CcSEcCtD
Dobutamine—Hypotension—Memantine—Alzheimer's disease	0.00473	0.0162	CcSEcCtD
Dobutamine—CA5B—nervous system—Alzheimer's disease	0.00467	0.0384	CbGeAlD
Dobutamine—Hypotension—Rivastigmine—Alzheimer's disease	0.00462	0.0158	CcSEcCtD
Dobutamine—CA2—telencephalon—Alzheimer's disease	0.00453	0.0372	CbGeAlD
Dobutamine—Dyspnoea—Memantine—Alzheimer's disease	0.00451	0.0154	CcSEcCtD
Dobutamine—Headache—Galantamine—Alzheimer's disease	0.0045	0.0154	CcSEcCtD
Dobutamine—CA5B—central nervous system—Alzheimer's disease	0.0045	0.0369	CbGeAlD
Dobutamine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00441	0.0151	CcSEcCtD
Dobutamine—COMT—nervous system—Alzheimer's disease	0.0043	0.0353	CbGeAlD
Dobutamine—Nausea—Galantamine—Alzheimer's disease	0.00427	0.0146	CcSEcCtD
Dobutamine—COMT—central nervous system—Alzheimer's disease	0.00414	0.034	CbGeAlD
Dobutamine—COMT—cerebellum—Alzheimer's disease	0.00405	0.0333	CbGeAlD
Dobutamine—Pruritus—Donepezil—Alzheimer's disease	0.00394	0.0135	CcSEcCtD
Dobutamine—Dopamine—MAOB—Alzheimer's disease	0.00368	0.127	CrCbGaD
Dobutamine—ADRB1—nervous system—Alzheimer's disease	0.00364	0.0299	CbGeAlD
Dobutamine—Pruritus—Memantine—Alzheimer's disease	0.00358	0.0123	CcSEcCtD
Dobutamine—CA5B—brain—Alzheimer's disease	0.00357	0.0293	CbGeAlD
Dobutamine—ADRB1—central nervous system—Alzheimer's disease	0.00351	0.0288	CbGeAlD
Dobutamine—Pruritus—Rivastigmine—Alzheimer's disease	0.0035	0.012	CcSEcCtD
Dobutamine—Headache—Donepezil—Alzheimer's disease	0.00349	0.012	CcSEcCtD
Dobutamine—Nausea—Donepezil—Alzheimer's disease	0.00331	0.0113	CcSEcCtD
Dobutamine—COMT—brain—Alzheimer's disease	0.00329	0.027	CbGeAlD
Dobutamine—Headache—Memantine—Alzheimer's disease	0.00317	0.0109	CcSEcCtD
Dobutamine—Headache—Rivastigmine—Alzheimer's disease	0.0031	0.0106	CcSEcCtD
Dobutamine—Nausea—Memantine—Alzheimer's disease	0.003	0.0103	CcSEcCtD
Dobutamine—Nausea—Rivastigmine—Alzheimer's disease	0.00294	0.0101	CcSEcCtD
Dobutamine—ADRB1—brain—Alzheimer's disease	0.00278	0.0229	CbGeAlD
Dobutamine—CA2—nervous system—Alzheimer's disease	0.00267	0.022	CbGeAlD
Dobutamine—CA2—central nervous system—Alzheimer's disease	0.00257	0.0211	CbGeAlD
Dobutamine—Arformoterol—CYP2D6—Alzheimer's disease	0.00253	0.0868	CrCbGaD
Dobutamine—Formoterol—CYP2D6—Alzheimer's disease	0.00253	0.0868	CrCbGaD
Dobutamine—CA2—cerebellum—Alzheimer's disease	0.00251	0.0207	CbGeAlD
Dobutamine—CA2—brain—Alzheimer's disease	0.00204	0.0168	CbGeAlD
Dobutamine—Labetalol—CYP2D6—Alzheimer's disease	0.00185	0.0635	CrCbGaD
Dobutamine—Dopamine—SLC6A4—Alzheimer's disease	0.00166	0.0572	CrCbGaD
Dobutamine—Dopamine—CYP2D6—Alzheimer's disease	0.00117	0.0402	CrCbGaD
Dobutamine—CA5A—Metabolism—LPL—Alzheimer's disease	0.000314	0.000564	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ENO1—Alzheimer's disease	0.000311	0.000559	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS1—Alzheimer's disease	0.000311	0.000559	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000307	0.000551	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP2D6—Alzheimer's disease	0.000305	0.000548	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.0003	0.000539	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.0003	0.000539	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GAL—Alzheimer's disease	0.000299	0.000537	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000294	0.000527	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—LPL—Alzheimer's disease	0.000293	0.000526	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GAL—Alzheimer's disease	0.000293	0.000525	CbGpPWpGaD
Dobutamine—CA2—Metabolism—BCHE—Alzheimer's disease	0.000289	0.000519	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MTHFR—Alzheimer's disease	0.000283	0.000508	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ACHE—Alzheimer's disease	0.000278	0.0005	CbGpPWpGaD
Dobutamine—COMT—Metabolism—INPP5D—Alzheimer's disease	0.000275	0.000494	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PLCB1—Alzheimer's disease	0.000273	0.00049	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GAL—Alzheimer's disease	0.000272	0.000488	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GAL—Alzheimer's disease	0.000266	0.000477	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TTR—Alzheimer's disease	0.000265	0.000475	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ABCA1—Alzheimer's disease	0.000265	0.000475	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CALM1—Alzheimer's disease	0.000264	0.000474	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MTHFR—Alzheimer's disease	0.000264	0.000474	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000263	0.000473	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—APOE—Alzheimer's disease	0.000263	0.000472	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS1—Alzheimer's disease	0.000261	0.000468	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ENO1—Alzheimer's disease	0.000261	0.000468	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CAV1—Alzheimer's disease	0.000261	0.000468	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	0.000259	0.000465	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000258	0.000462	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP2D6—Alzheimer's disease	0.000256	0.000459	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CALM1—Alzheimer's disease	0.000247	0.000443	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—APOE—Alzheimer's disease	0.000246	0.000441	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CAV1—Alzheimer's disease	0.000244	0.000437	CbGpPWpGaD
Dobutamine—COMT—Metabolism—BCHE—Alzheimer's disease	0.000243	0.000435	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—NPY—Alzheimer's disease	0.000235	0.000422	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000235	0.000421	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000234	0.00042	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000234	0.000419	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PYY—Alzheimer's disease	0.000232	0.000416	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	0.00023	0.000413	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.00023	0.000412	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARG—Alzheimer's disease	0.000229	0.000412	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PLCB1—Alzheimer's disease	0.000229	0.000411	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000229	0.000411	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	0.000229	0.00041	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000228	0.00041	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARGC1A—Alzheimer's disease	0.000228	0.000409	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HMOX1—Alzheimer's disease	0.000227	0.000408	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	0.000227	0.000407	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	0.000227	0.000406	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—INS—Alzheimer's disease	0.000225	0.000404	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000224	0.000402	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	0.000222	0.000398	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ABCA1—Alzheimer's disease	0.000222	0.000398	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000215	0.000386	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARG—Alzheimer's disease	0.000214	0.000384	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	0.000213	0.000383	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000212	0.000381	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	0.00021	0.000377	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—INS—Alzheimer's disease	0.00021	0.000377	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	0.000209	0.000375	CbGpPWpGaD
Dobutamine—CA2—Metabolism—LPL—Alzheimer's disease	0.000208	0.000373	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	0.000207	0.000372	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	0.000206	0.00037	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000205	0.000368	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	0.000205	0.000368	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	0.000201	0.000361	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	0.000201	0.00036	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	0.000201	0.00036	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000201	0.00036	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	0.000201	0.00036	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	0.0002	0.000359	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—NOS3—Alzheimer's disease	0.000197	0.000354	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	0.000196	0.000352	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	0.000196	0.000352	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	0.000195	0.000351	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	0.000195	0.00035	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000194	0.000349	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	0.000193	0.000347	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARGC1A—Alzheimer's disease	0.000191	0.000343	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	0.000191	0.000343	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HMOX1—Alzheimer's disease	0.00019	0.000342	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.00019	0.000341	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	0.000189	0.000339	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000189	0.000338	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MTHFR—Alzheimer's disease	0.000187	0.000336	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000186	0.000334	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	0.000186	0.000334	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000184	0.000331	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—NOS3—Alzheimer's disease	0.000184	0.00033	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	0.000182	0.000327	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	0.000182	0.000327	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	0.000181	0.000326	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—Alzheimer's disease	0.00018	0.000324	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000179	0.000321	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	0.000178	0.000319	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000175	0.000315	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	0.000175	0.000314	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CALM1—Alzheimer's disease	0.000175	0.000314	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOE—Alzheimer's disease	0.000174	0.000312	CbGpPWpGaD
Dobutamine—COMT—Metabolism—LPL—Alzheimer's disease	0.000174	0.000312	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	0.000173	0.000311	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CAV1—Alzheimer's disease	0.000172	0.00031	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	0.000172	0.000308	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000171	0.000307	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	0.000169	0.000304	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000168	0.000302	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—Alzheimer's disease	0.000168	0.000302	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000168	0.000301	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	0.000165	0.000296	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	0.000164	0.000295	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	0.000161	0.000288	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	0.000161	0.000288	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	0.000161	0.000288	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	0.000157	0.000282	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	0.000157	0.000282	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MTHFR—Alzheimer's disease	0.000157	0.000281	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—Alzheimer's disease	0.000152	0.000272	CbGpPWpGaD
Dobutamine—CA2—Metabolism—INS—Alzheimer's disease	0.000149	0.000267	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CALM1—Alzheimer's disease	0.000146	0.000263	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOE—Alzheimer's disease	0.000146	0.000262	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CAV1—Alzheimer's disease	0.000145	0.000259	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	0.000141	0.000254	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000139	0.00025	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	0.000138	0.000248	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000137	0.000246	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000136	0.000245	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	0.000134	0.00024	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000132	0.000237	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NOS3—Alzheimer's disease	0.00013	0.000234	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000129	0.000232	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000129	0.000232	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—Alzheimer's disease	0.000127	0.000228	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000127	0.000227	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000126	0.000227	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	0.000126	0.000226	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	0.000125	0.000225	CbGpPWpGaD
Dobutamine—COMT—Metabolism—INS—Alzheimer's disease	0.000125	0.000224	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000124	0.000222	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	0.000123	0.000221	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	0.000123	0.00022	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	0.000122	0.000218	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	0.00012	0.000215	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—Alzheimer's disease	0.000119	0.000214	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	0.000119	0.000214	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000117	0.000211	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	0.000117	0.000211	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	0.000115	0.000207	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000115	0.000206	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000115	0.000206	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	0.000113	0.000203	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000113	0.000203	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	0.000113	0.000202	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000112	0.000201	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	0.000111	0.000199	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	0.000111	0.000199	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	0.00011	0.000197	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SST—Alzheimer's disease	0.00011	0.000197	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	0.00011	0.000197	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	0.00011	0.000197	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NOS3—Alzheimer's disease	0.000109	0.000196	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000109	0.000196	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	0.000108	0.000193	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SST—Alzheimer's disease	0.000108	0.000193	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	0.000108	0.000193	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APP—Alzheimer's disease	0.000107	0.000192	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	0.000107	0.000192	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	0.000107	0.000191	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APP—Alzheimer's disease	0.000105	0.000188	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	0.000103	0.000185	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000101	0.000182	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	0.000101	0.000181	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—Alzheimer's disease	0.0001	0.000179	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	9.9e-05	0.000178	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	9.44e-05	0.000169	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	9.38e-05	0.000168	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	9.23e-05	0.000166	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	9.22e-05	0.000165	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	9.18e-05	0.000165	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	9.17e-05	0.000165	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—Alzheimer's disease	9.07e-05	0.000163	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	9.02e-05	0.000162	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	8.98e-05	0.000161	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	8.72e-05	0.000156	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	8.53e-05	0.000153	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—Alzheimer's disease	8.46e-05	0.000152	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	8.3e-05	0.000149	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	8.12e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	8.03e-05	0.000144	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	7.85e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	7.69e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	7.62e-05	0.000137	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	7.53e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	7.48e-05	0.000134	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	7.46e-05	0.000134	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	7.32e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	7.29e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	7.13e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	7.09e-05	0.000127	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	6.94e-05	0.000124	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	6.93e-05	0.000124	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	6.79e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	6.47e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	6.45e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	6.45e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	6.39e-05	0.000115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	6.33e-05	0.000114	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	6.31e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	6.31e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	6.25e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	6.16e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—F2—Alzheimer's disease	6.08e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	6.02e-05	0.000108	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—Alzheimer's disease	6e-05	0.000108	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.95e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—F2—Alzheimer's disease	5.95e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.82e-05	0.000104	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	5.59e-05	0.0001	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	5.54e-05	9.94e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INS—Alzheimer's disease	5.51e-05	9.89e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	5.46e-05	9.8e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	5.42e-05	9.73e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	5.42e-05	9.73e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INS—Alzheimer's disease	5.39e-05	9.67e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	5.33e-05	9.56e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	5.3e-05	9.52e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	5.21e-05	9.35e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—Alzheimer's disease	5.02e-05	9.02e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	4.83e-05	8.67e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	4.73e-05	8.48e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.14e-05	7.43e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	4.1e-05	7.36e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	4.08e-05	7.31e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.05e-05	7.27e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	4.01e-05	7.2e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	3.99e-05	7.15e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	3.77e-05	6.77e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	3.76e-05	6.75e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	3.69e-05	6.62e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	3.68e-05	6.6e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	3.48e-05	6.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	3.4e-05	6.11e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	3.19e-05	5.73e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	3.13e-05	5.61e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	2.63e-05	4.72e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	2.57e-05	4.62e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	2.41e-05	4.32e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	2.35e-05	4.23e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.22e-05	3.99e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.17e-05	3.9e-05	CbGpPWpGaD
